Can LH (Luteinizing Hormone) and FSH (Follicle-Stimulating Hormone) levels be completely flatlined in cases of Functional Hypothalamic Amenorrhea (FHA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can LH and FSH Be Completely Flatlined in FHA?

Yes, LH and FSH can be completely flatlined (undetectable or <2 IU/L) in severe cases of Functional Hypothalamic Amenorrhea, though the more typical presentation is "low-normal" levels. 1

The Spectrum of Gonadotropin Suppression in FHA

The hormonal presentation in FHA exists on a spectrum of GnRH pulsatile suppression severity:

  • The hallmark finding is "low-normal" FSH and LH levels (typically in the 2-5 IU/L range), which represents the most common presentation and helps distinguish FHA from other causes of amenorrhea 2

  • However, severe cases can present with both LH and FSH <2 IU/L, which represents profound hypothalamic suppression and is sometimes referred to as hypothalamic hypogonadism (HH) 1

  • The spectrum of GnRH-LH disturbances in FHA is very broad and includes lower mean frequency of LH pulses, complete absence of LH pulsatility, normal-appearing secretion patterns, and even higher mean frequency of LH pulses in some cases 3

Clinical Context Matters

The degree of gonadotropin suppression correlates with severity of the underlying trigger:

  • Patients with more severe energy deficits, lower body weight, or more intense psychological stress tend to have more profound suppression of the hypothalamic-pituitary-gonadal axis 4

  • The fundamental pathophysiology involves reduced pulsatile secretion of GnRH from the hypothalamus, which leads to decreased LH pulse frequency and reduced FSH secretion 5

  • In some studies defining FHA with strict criteria, patients had to have both LH and FSH <2 IU/L to distinguish them from other conditions, demonstrating that this degree of suppression is recognized in the literature 1

Diagnostic Implications

When you encounter completely flatlined gonadotropins:

  • LH and FSH both <2 IU/L with estradiol <100 pmol/L strongly indicates hypothalamic hypogonadism/severe FHA rather than PCOS or other conditions 1

  • This pattern requires careful evaluation to exclude other causes of hypogonadotropic hypogonadism including Kallmann syndrome, normosmic idiopathic hypogonadotropic hypogonadism, drug-induced suppression (opiates, anabolic steroids), or pituitary pathology 5

  • The clinical context is critical: a clear history of energy deficit, caloric restriction, excessive exercise, or psychological stress in a young woman with amenorrhea supports FHA even with undetectable gonadotropins 2

Common Pitfall to Avoid

  • Do not assume that "low-normal" means gonadotropins cannot be lower - the term "low-normal" describes the typical presentation, but severe FHA can present with profoundly suppressed or undetectable levels 1, 2

  • Approximately 29% of FHA patients have serum basal FSH <4.5 IU/L (below the 5th percentile of normal values), and some will have even lower levels approaching undetectable ranges 6

  • The key distinguishing feature from primary ovarian insufficiency is that POI shows FSH >40 IU/L, the complete opposite of FHA 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Functional Hypothalamic Amenorrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Functional hypothalamic amenorrhea: current view on neuroendocrine aberrations.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2008

Guideline

Causes of Low FSH and LH

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

FSH and LH Levels in Primary Ovarian Insufficiency

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Do the blood results align with the hypothesis of functional hypothalamic amenorrhea (FHA)?
What is the diagnosis for a 16-year-old girl with secondary amenorrhea (absence of menstruation), normal Thyroid-Stimulating Hormone (TSH), Follicle-Stimulating Hormone (FSH), and Luteinizing Hormone (LH) levels, and recent significant weight loss with reduced appetite?
What is the recommended treatment plan for a 23-year-old female with hypothalamic amenorrhea (HA) due to rapid weight loss, chronic stress, and anxiety, with lab results showing elevated Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) levels, low Estradiol levels, and thrombocytopenia (low platelet count)?
Does the patient's history of irregular menstrual cycles, amenorrhea, and response to letrozole (letrozole) and metformin (metformin) support a diagnosis of Functional Hypothalamic Amenorrhea (FHA)?
Are menstrual cycle lengths of 47, 38, and 40 days concerning in the context of Functional Hypothalamic Amenorrhea (FHA), 6 months of amenorrhea, and letrozole (Femara) induction?
What is the recommended antiplatelet regimen after Coronary Artery Bypass Grafting (CABG) and what is the typical duration of treatment?
What is the next step in managing a patient with persistent asthma despite being on albuterol (short-acting beta-agonist) inhaler and ipratropium (anticholinergic)/albuterol (short-acting beta-agonist) nebulizer?
When are proximal phalanx fractures considered for surgical intervention?
What is the recommended treatment approach for prostatitis in elderly patients?
What is the workup for lightheadedness in an elderly patient on clozapine (Clozaril)?
What characterizes a high-risk exacerbation of Chronic Obstructive Pulmonary Disease (COPD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.